This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. The contract has a ceiling value of $2,015.75 and is a firm fixed-price delivery order with a final completion date of September 13, 2024. The contract does not have a set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the Trelegy Ellipta medication to support the DLA's medical supply needs, which include serving military treatment facilities and other federal healthcare providers. This contract award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies.
Generated 12/12/24, 9:32 AM